Price alert —
Sign in to get a one-time email the moment CAH crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · CAH
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60.9B | $0.4B | $0.8B | $1.7B | 0.7% | 1.4% |
| 2025-12-31 | $65.6B | $0.5B | $0.8B | $0.6B | 0.7% | 1.2% |
| 2025-09-30 | $64.0B | $0.5B | $0.8B | $0.9B | 0.7% | 1.2% |
| 2025-06-30 | $60.2B | $0.2B | $0.6B | $1.3B | 0.4% | 1.0% |
| 2025-03-31 | $54.9B | $0.5B | $0.7B | $2.8B | 0.9% | 1.2% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare CAH vs peers
Line CAH up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with CAH
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-04-30 | 3.17 | 2.79 | +13.7% | +1.2% |
| 2026-02-05 | 2.63 | 2.37 | +11.2% | -0.4% |
| 2025-10-30 | 2.55 | 2.17 | +17.6% | +0.5% |
| 2025-08-12 | 2.08 | 2.03 | +2.4% | +1.2% |
| 2025-05-01 | 2.35 | 2.15 | +9.4% | +2.8% |
| 2025-01-30 | 1.93 | 1.76 | +9.4% | -3.6% |
| 2024-11-01 | 1.88 | 1.62 | +15.9% | -3.6% |
| 2024-08-14 | 1.84 | 1.73 | +6.3% | +1.5% |
| 2024-05-02 | 2.08 | 1.95 | +6.6% | -4.0% |
| 2024-02-01 | 1.82 | 1.60 | +14.0% | -1.6% |
| 2023-11-03 | 1.73 | 1.41 | +23.0% | +1.4% |
| 2023-08-15 | 1.55 | 1.48 | +4.9% | -0.2% |
| 2023-05-04 | 1.74 | 1.49 | +16.8% | +2.9% |
| 2023-02-02 | 1.32 | 1.14 | +15.3% | +3.1% |
| 2022-11-04 | 1.20 | 0.97 | +24.1% | +1.8% |
| 2022-08-11 | 1.05 | 1.18 | -11.2% | +5.0% |
| 2022-05-05 | 1.45 | 1.53 | -5.0% | +0.7% |
| 2022-02-03 | 1.27 | 1.23 | +3.1% | +1.0% |
| 2021-11-09 | 1.29 | 1.35 | -4.3% | +2.0% |
| 2021-08-05 | 0.77 | 1.20 | -35.7% | +0.8% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| CAH ★ | $54B | 34.8 | 19.0 | 0.2 | 14.7 | -19.0 | 3.8% | 11.0% | -19.5% | 9.06% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 41.5%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 28,494,855 | 12.17% |
| Vanguard Capital Management LLC | 15,288,709 | 6.53% |
| Vanguard Portfolio Management LLC | 13,732,309 | 5.86% |
| State Street Corporation | 12,074,518 | 5.16% |
| Geode Capital Management, LLC | 6,580,532 | 2.81% |
| Morgan Stanley | 4,954,328 | 2.12% |
| Wellington Management Group, LLP | 4,276,152 | 1.83% |
| FMR, LLC | 4,243,240 | 1.81% |
| WCM Investment Management, LLC | 4,006,636 | 1.71% |
| Invesco Ltd. | 3,512,241 | 1.50% |
Insider activity · 90d
No insider trades for CAH in last 90d.
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 10-Q | 2026-04-30 | 10-Q | view · |
| 8-K | 2026-04-30 | 8-K | view · |
| 4 | 2026-04-17 | FORM 4 | view · |
| 8-K | 2026-03-23 | 8-K | view · |
| 8-K | 2026-03-05 | 8-K | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 4 | 2026-02-10 | FORM 4 | view · |
| 10-Q | 2026-02-05 | 10-Q | view · |
| 8-K | 2026-02-05 | 8-K | view · |
| 4 | 2026-01-20 | FORM 4 | view · |
| 8-K | 2026-01-13 | 8-K | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 8-K | 2025-11-06 | 8-K | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 4 | 2025-11-06 | FORM 4 | view · |
| 10-Q | 2025-10-30 | 10-Q | view · |
| 8-K | 2025-10-30 | 8-K | view · |
| 8-K | 2025-10-10 | 8-K | view · |
| 8-K | 2025-10-03 | 8-K | view · |
| DEF 14A | 2025-09-16 | DEF 14A | view · |
| 8-K | 2025-08-27 | 8-K | view · |
| 4 | 2025-08-20 | FORM 4 | view · |
| 4 | 2025-08-20 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 4 | 2025-08-19 | FORM 4 | view · |
| 8-K | 2025-08-14 | 8-K | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 4 | 2025-08-12 | FORM 4 | view · |
| 10-K | 2025-08-12 | 10-K | view · |
| 8-K | 2025-08-12 | 8-K | view · |
| 4 | 2025-06-30 | FORM 4 | view · |
| 4 | 2025-06-30 | FORM 4 | view · |
| 4 | 2025-06-30 | FORM 4 | view · |
| 4 | 2025-06-30 | FORM 4 | view · |
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, a…
Options picks · CAH
ITM + OTM ideas from the latest scanLoading…
Congress trades · CAH
STOCK Act disclosuresLoading…
SEC filings & insiders · CAH
EDGAR · liveLoading…
Holders · CAH
Institutions & insider activityLoading…